Skip to main content

ADVERTISEMENT

laser

Original Contribution
05/11/2022

Nicolas W. Shammas, MD1; Gail A Shammas, RN1; Grace Halupnik, MD1; Nicholas Fedele, MD1; Katie Comp, MD1; Emma-Marie Taleb, MD1;
Sue Jones-Miller, MD1; Andrew N. Shammas, MD1; Venkat Shankarraman, MD2

Nicolas W. Shammas, MD1; Gail A Shamm...
The Auryon 355-nm laser atherectomy system (AngioDynamics, Inc) showed a low rate of target-lesion revascularization (TLR) at 6-month follow-up in the investigational device exemption study. At present, real-world data are not available. The...
The Auryon 355-nm laser atherectomy system (AngioDynamics, Inc) showed a low rate of target-lesion revascularization (TLR) at 6-month follow-up in the investigational device exemption study. At present, real-world data are not available. The...
The Auryon 355-nm laser...
05/11/2022
Journal of Invasive Cardiology
Original Contribution
03/15/2018

Judit Karacsonyi, MD1,2;  Ehrin J. Armstrong, MD, MSc3;  Huu Tam D. Truong, MD4;  Ryan Tsuda, MD4;  Damianos G. Kokkinidis, MD3;  Jose Roberto Martinez-Parachini, MD1;  Aya J. Alame, BA1;  Barbara A. Danek, MD1;  Aris Karatasakis, MD1;  Michele Roesle, RN1;  Houman Khalili, MD1;  Imre Ungi, MD, PhD2;  Subhash Banerjee, MD1;  Emmanouil S. Brilakis, MD, PhD1,5;  Bavana V. Rangan, BDS, MPH1

Judit Karacsonyi, MD1,2;  Ehrin J. Ar...
We examined the baseline clinical and angiographic characteristics and procedural outcomes of 130 target lesions in 121 consecutive PCIs (n = 116 patients) in which excimer laser coronary atherectomy was performed at three United States...
We examined the baseline clinical and angiographic characteristics and procedural outcomes of 130 target lesions in 121 consecutive PCIs (n = 116 patients) in which excimer laser coronary atherectomy was performed at three United States...
We examined the baseline...
03/15/2018
Journal of Invasive Cardiology